The current status of biomarkers for predicting toxicity

INTRODUCTION: There are significant rates of attrition in drug development. A number of compounds fail to progress past preclinical development due to limited tools that accurately monitor toxicity in preclinical studies and in the clinic. Research has focused on improving tools for the detection of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Campion, Sarah, Aubrecht, Jiri, Boekelheide, Kim, Brewster, David W, Vaidya, Vishal S, Anderson, Linnea, Burt, Deborah, Dere, Edward, Hwang, Kathleen, Pacheco, Sara, Saikumar, Janani, Schomaker, Shelli, Sigman, Mark, Goodsaid, Federico
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870154/
https://ncbi.nlm.nih.gov/pubmed/23961847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425255.2013.827170
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares